DK0814837T3 - Anvendelse af G-klasse-immunoglobuliner til topikal behandling af atopisk dermatitis - Google Patents

Anvendelse af G-klasse-immunoglobuliner til topikal behandling af atopisk dermatitis

Info

Publication number: DK0814837T3
Authority: DK; Denmark
Prior art keywords: dermatitis; immunoglobulins; atopic dermatitis; class immunoglobulins; topical treatment
Prior art date: 1995-03-14

Application number

DK96905988T

Other languages

English (en)

Other versions

DK0814837T4 (da

Inventor

Simone Claudio De

Pietro Bruschi

Original Assignee

Vsl Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-03-14

Filing date

1996-03-12

Publication date

2003-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11403139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0814837(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-03-12 Application filed by Vsl Pharma Ltd filed Critical Vsl Pharma Ltd

2003-03-31 Publication of DK0814837T3 publication Critical patent/DK0814837T3/da

2006-05-29 Application granted granted Critical

2006-05-29 Publication of DK0814837T4 publication Critical patent/DK0814837T4/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Microbiology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Virology (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK96905988T 1995-03-14 1996-03-12 Anvendelse af G-klasse-immunoglobuliner til topikal behandling af atopisk dermatitis DK0814837T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT95RM000154A IT1278052B1 (it)	1995-03-14	1995-03-14	Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per
PCT/IT1996/000047 WO1996028186A1 (en)	1995-03-14	1996-03-12	Use of g class immunoglobulins for the topical treatment of atopic dermatitis

Publications (2)

Publication Number	Publication Date
DK0814837T3 true DK0814837T3 (da)	2003-03-31
DK0814837T4 DK0814837T4 (da)	2006-05-29

Family

ID=11403139

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96905988T DK0814837T4 (da)	1995-03-14	1996-03-12	Anvendelse af G-klasse-immunoglobuliner til topikal behandling af atopisk dermatitis

Country Status (12)

Country	Link
US (2)	US6410019B1 (da)
EP (1)	EP0814837B2 (da)
JP (1)	JP3939346B2 (da)
KR (1)	KR19980702515A (da)
AT (1)	ATE228854T1 (da)
CA (1)	CA2213500C (da)
DE (1)	DE69625182T3 (da)
DK (1)	DK0814837T4 (da)
ES (1)	ES2187635T5 (da)
IT (1)	IT1278052B1 (da)
PT (1)	PT814837E (da)
WO (1)	WO1996028186A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030059428A1 (en) *	1993-02-26	2003-03-27	Boris Skurkovich	Treatment of autoimmune diseases
WO2003001985A2 (en) *	2001-06-28	2003-01-09	Dermtech International	Method for detection of melanoma
RU2235556C1 (ru) *	2003-02-13	2004-09-10	Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН	Способ лечения атопического дерматита
US7183057B2 (en) *	2004-03-31	2007-02-27	Dermtech International	Tape stripping methods for analysis of skin disease and pathological skin state
US20080274908A1 (en) *	2007-05-04	2008-11-06	Dermtech International	Diagnosis of melanoma by nucleic acid analysis
EP2626437A3 (en)	2008-05-14	2013-12-11	Dermtech International	Diagnosis of melanoma and solar lentigo by nucleic acid analysis
US20100086501A1 (en) *	2008-08-28	2010-04-08	Dermtech International	Determining Age Ranges of Skin Samples
US20130039903A1 (en) *	2010-04-23	2013-02-14	Probiotec Limited	Eczema treatment
EP3752645A4 (en)	2018-02-14	2022-04-13	Dermtech, Inc.	Novel gene classifiers and uses thereof in non-melanoma skin cancers
JP2022524641A (ja)	2019-03-26	2022-05-09	ダームテック，インク．	皮膚癌における新規な遺伝子分類子とその使用
US20240182552A1 (en) *	2021-04-07	2024-06-06	Ajou University Industry-Academic Cooperation Foundation	Pharmaceutical composition for preventing or treating immune dysregulation-related diseases comprising oxidized immunoglobulin as active ingredient

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2610854A1 (de) *	1976-03-15	1977-09-22	Biotest Serum Institut Gmbh	Galenische immunglobulinzubereitung
ATE39842T1 (de) *	1983-06-07	1989-01-15	Stolle Res & Dev	Desodorant das bakterielle antikoerper enthaelt.
US5141742A (en) *	1986-02-07	1992-08-25	Oncogen	Vaccines against melanoma
ATE118350T1 (de) *	1988-07-22	1995-03-15	Morris John Co Inc	Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung.
US5571511A (en) *	1990-10-22	1996-11-05	The U.S. Government	Broadly reactive opsonic antibodies that react with common staphylococcal antigens
FR2669538B1 (fr) *	1990-11-28	1995-03-03	Fondation Nale Transfusion San	Utilisation d'immunoglobulines administrees localement dans le traitement des infections epitheliales.
EP0680337A4 (en)	1993-01-12	1997-07-30	Anthony George Gristina	METHODS AND COMPOSITIONS FOR DIRECT APPLICATION WITH HIGH CONCENTRATION OF ANTIBODIES, PRODUCING PASSIVE IMMUNITY.
JP3193205B2 (ja) *	1993-08-09	2001-07-30	日本臓器製薬株式会社	好酸球増多抑制剤

1995
- 1995-03-14 IT IT95RM000154A patent/IT1278052B1/it active IP Right Grant
1996
- 1996-03-12 EP EP96905988A patent/EP0814837B2/en not_active Expired - Lifetime
- 1996-03-12 ES ES96905988T patent/ES2187635T5/es not_active Expired - Lifetime
- 1996-03-12 CA CA2213500A patent/CA2213500C/en not_active Expired - Fee Related
- 1996-03-12 KR KR1019970705915A patent/KR19980702515A/ko not_active Ceased
- 1996-03-12 AT AT96905988T patent/ATE228854T1/de not_active IP Right Cessation
- 1996-03-12 WO PCT/IT1996/000047 patent/WO1996028186A1/en not_active Ceased
- 1996-03-12 DE DE69625182T patent/DE69625182T3/de not_active Expired - Lifetime
- 1996-03-12 US US08/913,339 patent/US6410019B1/en not_active Expired - Fee Related
- 1996-03-12 DK DK96905988T patent/DK0814837T4/da active
- 1996-03-12 PT PT96905988T patent/PT814837E/pt unknown
- 1996-03-12 JP JP52743196A patent/JP3939346B2/ja not_active Expired - Fee Related
2002
- 2002-05-20 US US10/147,855 patent/US7217416B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR19980702515A (ko)	1998-07-15
ITRM950154A0 (it)	1995-03-14
EP0814837A1 (en)	1998-01-07
JP3939346B2 (ja)	2007-07-04
WO1996028186A1 (en)	1996-09-19
EP0814837B2 (en)	2006-02-22
CA2213500A1 (en)	1996-09-19
US20020192276A1 (en)	2002-12-19
DE69625182D1 (de)	2003-01-16
ES2187635T3 (es)	2003-06-16
PT814837E (pt)	2003-04-30
US7217416B2 (en)	2007-05-15
DE69625182T2 (de)	2003-11-20
CA2213500C (en)	2010-01-26
US6410019B1 (en)	2002-06-25
EP0814837B1 (en)	2002-12-04
ES2187635T5 (es)	2006-09-01
ATE228854T1 (de)	2002-12-15
IT1278052B1 (it)	1997-11-17
DK0814837T4 (da)	2006-05-29
DE69625182T3 (de)	2006-08-24
ITRM950154A1 (it)	1996-09-14
JPH11501915A (ja)	1999-02-16

Publication	Publication Date	Title
NO994256L (no)	1999-11-02	Små molekyler som er anvendelige ved behandling av inflammasjonssykdom
DE69129800D1 (de)	1998-08-20	Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
DK0814837T4 (da)	2006-05-29	Anvendelse af G-klasse-immunoglobuliner til topikal behandling af atopisk dermatitis
ATE300298T1 (de)	2005-08-15	Behandlung von leukocyten durch photopheresis
AU3142195A (en)	1996-05-15	Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation
ATE103813T1 (de)	1994-04-15	Topische metronidazol-formulationen und deren verwendung als arzneimittel.
DE69431476D1 (de)	2002-11-07	Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung
NO980317L (no)	1998-03-24	Anvendelse av Calendula-glykosider for behandling av psoriasis
AU3902299A (en)	1999-12-30	Methods of treating microbial infection and therapeutic formulations therefor
MX9603596A (es)	1997-06-28	Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
ATE193442T1 (de)	2000-06-15	3,4-diarylchromane zur behandlung von dermatitis
ATE77230T1 (de)	1992-07-15	Melatoninhaltige mittel sowie deren verwendungen.
CA2157836A1 (en)	1996-03-09	L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
BR9712141A (pt)	1999-08-31	Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
MX9302279A (es)	1994-08-31	Metodo para la produccion del factor viii presenteen el plasma, altamente purificado.
TR199700694T1 (xx)	1998-02-21	D vitamini t�revlerinin dermotolojik kullan�m�.
DK0700897T3 (da)	1999-02-01	L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
TR199900662T2 (xx)	1999-06-21	1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
DE69424563D1 (de)	2000-06-21	Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis
ATE245991T1 (de)	2003-08-15	Behandlung chronischer entzündungskrankheiten mit cm101/gbs-toxin
RU94041246A (ru)	1996-10-10	Способ лечения псориаза
NO962619D0 (no)	1996-06-20	Psoriasisbehandling
ATE147983T1 (de)	1997-02-15	Transdermales therapeutisches system mit pentylentetrazol als wirkstoff
UA10928C2 (uk)	1996-12-25	Спосіб профілактики гіперхолестериhемії
GEU1998400Y (en)	1998-11-30	Ointment “Topokril” for Treating of Dermatitis